Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Imaging analysis quantifies benefit of drug on eyelid swelling
Boston-A study using a novel, objective method for quantifying eyelid swelling reinforces the benefit of olopatadine HCl 0.1% (Patanol, Alcon) for reducing eyelid swelling triggered by allergen exposure, said Mark B. Abelson, MD.
Related Videos
Related Content
